Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethynylcytidine is a nucleoside antimetabolite.
In vivo | In both OCUM-2MD3 and LX-1 xenograft models, Ethynylcytidine demonstrates notable tumor regression and a potent antitumor efficacy, achieving a tumor growth inhibition (IR) rate of about 90% or higher by day 15 at minimally toxic doses across all three dosing schedules. Specifically, a weekly administration of Ethynylcytidine at 6 mg/kg leads to a significant reduction in LX-1 tumor size, with an IR of 98%. Conversely, administering Ethynylcytidine three or five times weekly yields a strong antitumor response with an IR of approximately 85%, whereas a once-weekly treatment regimen results in a less than 60% IR, indicating a comparatively weaker antitumor activity. |
別名 | ECyD, 3'-C-Ethynylcytidine, TAS-106 |
分子量 | 267.24 |
分子式 | C11H13N3O5 |
CAS No. | 180300-43-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 240 mg/mL (898.07 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ethynylcytidine 180300-43-0 Cell Cycle/Checkpoint DNA Damage/DNA Repair Nucleoside Antimetabolite/Analog ECyD 3'-C-Ethynylcytidine TAS106 TAS 106 TAS-106 Inhibitor inhibitor inhibit